全文获取类型
收费全文 | 2562篇 |
免费 | 315篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 91篇 |
妇产科学 | 50篇 |
基础医学 | 235篇 |
口腔科学 | 9篇 |
临床医学 | 482篇 |
内科学 | 655篇 |
皮肤病学 | 31篇 |
神经病学 | 294篇 |
特种医学 | 62篇 |
外科学 | 428篇 |
综合类 | 19篇 |
预防医学 | 237篇 |
眼科学 | 22篇 |
药学 | 140篇 |
中国医学 | 2篇 |
肿瘤学 | 108篇 |
出版年
2023年 | 27篇 |
2022年 | 13篇 |
2021年 | 34篇 |
2020年 | 31篇 |
2019年 | 46篇 |
2018年 | 81篇 |
2017年 | 86篇 |
2016年 | 67篇 |
2015年 | 101篇 |
2014年 | 105篇 |
2013年 | 141篇 |
2012年 | 152篇 |
2011年 | 148篇 |
2010年 | 93篇 |
2009年 | 80篇 |
2008年 | 121篇 |
2007年 | 119篇 |
2006年 | 138篇 |
2005年 | 95篇 |
2004年 | 80篇 |
2003年 | 81篇 |
2002年 | 85篇 |
2001年 | 77篇 |
2000年 | 69篇 |
1999年 | 72篇 |
1998年 | 41篇 |
1997年 | 33篇 |
1996年 | 29篇 |
1995年 | 32篇 |
1994年 | 17篇 |
1993年 | 30篇 |
1992年 | 65篇 |
1991年 | 55篇 |
1990年 | 63篇 |
1989年 | 58篇 |
1988年 | 52篇 |
1987年 | 34篇 |
1986年 | 41篇 |
1985年 | 40篇 |
1984年 | 24篇 |
1983年 | 32篇 |
1982年 | 5篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 17篇 |
1977年 | 6篇 |
1974年 | 7篇 |
1972年 | 5篇 |
1968年 | 6篇 |
1967年 | 5篇 |
排序方式: 共有2884条查询结果,搜索用时 15 毫秒
61.
62.
63.
Diagnostic value of ascitic fluid cholesterol levels in the prediction of malignancy 总被引:1,自引:0,他引:1
P B Mortensen S D Kristensen A Bloch B A Jacobsen S N Rasmussen 《Scandinavian journal of gastroenterology》1988,23(9):1085-1088
In a prospective study abdominal paracentesis with ascitic fluid aspiration was performed in 54 consecutive patients with ascites of unknown cause. The ascitic fluid was examined cytologically and bacteriologically. The total cholesterol concentration was measured with an enzymatic colorimetric method. Malignant disease was diagnosed in 34 patients. Two of them had both malignant disease and liver cirrhosis and were excluded. Seventeen patients had liver cirrhosis, one had acute pancreatitis, and two had decompensated heart disease. The diagnostic value of an ascitic cholesterol concentration greater than 1.2 mmol/l in terms of predicting malignant disease was 87.5% (95% confidence limits, 71.0-96.5). The predictive value of an ascitic cholesterol concentration less than or equal to 1.2 mmol/l in terms of benign disease was 80.0% (95% confidence limits, 56.3-94.3). It is concluded that ascitic cholesterol measurement is a valuable supplement to cytologic examination in distinguishing between ascites of malignant and benign origin. 相似文献
64.
The surgical management of perianal Crohn's disease is complex with a wide range of operations being described. The initial emergency treatment is to drain any source of underlying sepsis. A loose seton drainage or a defunctioning stoma can then be used as a 'bridge' to definitive treatment allowing both adequate assessment of the condition and preventing further sepsis. The likelihood of success of any surgical repair must be weighed against the risk of faecal incontinence. Improved results of a local surgical repair are seen with optimal surgical and medical management of perianal Crohn's disease. 相似文献
65.
Hawkey C Laine L Simon T Beaulieu A Maldonado-Cocco J Acevedo E Shahane A Quan H Bolognese J Mortensen E 《Arthritis and rheumatism》2000,43(2):370-377
OBJECTIVE: This randomized, double-blind study tested the hypothesis that rofecoxib, a drug that specifically inhibits cyclooxygenase 2, would cause fewer gastroduodenal ulcers than ibuprofen (in a multicenter trial), and its side effects would be equivalent to those of placebo (in a prespecified analysis combining the results with another trial of identical design). METHODS: Seven hundred seventy-five patients with osteoarthritis were randomized to receive rofecoxib at a dosage of 25 mg or 50 mg once daily, ibuprofen 800 mg 3 times daily, or placebo. Gastroduodenal ulceration was assessed by endoscopy at 6, 12, and (for active treatment) 24 weeks. The primary and secondary end points were the incidence of gastroduodenal ulcers at 12 and 24 weeks, respectively. RESULTS: Ulcers were significantly less common (P < 0.001) following treatment with rofecoxib (25 mg or 50 mg) than with ibuprofen after 12 weeks (5.3% and 8.8% versus 29.2%, respectively) or 24 weeks (9.9% and 12.4% versus 46.8%, respectively). In the combined analysis, the 12-week ulcer incidence with 25 mg rofecoxib (4.7%) and with placebo (7.3%) satisfied prespecified criteria for equivalence. CONCLUSION: At 2-4 times the therapeutically effective dose, rofecoxib caused fewer endoscopically detected ulcers than did ibuprofen. Rofecoxib at a dose of 25 mg (the highest dose recommended for osteoarthritis) satisfied prespecified criteria for equivalence to placebo. 相似文献
66.
Nerve mediated relaxation of the human internal anal sphincter: the role of nitric oxide. 总被引:18,自引:4,他引:18
下载免费PDF全文
![点击此处可从《Gut》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The aim of this study was to determine if nitric oxide (NO) is the non-adrenergic, non-cholinergic neurotransmitter, released by enteric inhibitory nerves, which mediates relaxation of the human internal anal sphincter. Isolated muscle strips were mounted for isometric tension recording in superfusion organ baths. Sodium nitroprusside, an exogenous donor of NO, relaxed the strips in a concentration dependent manner. In the presence of atropine and guanethidine, transmural field stimulation produced tetrodotoxin sensitive relaxations, which were inhibited in a dose dependent and enantiomer specific manner by antagonists of NO synthase; completely by L-nitroarginine and partially by L-N-monomethyl arginine. The effect of these antagonists was reversed by L-arginine but not D-arginine. Oxyhaemoglobin, a scavenger of nitric oxide, also abolished the relaxations but methaemoglobin had no such effect. These results strongly suggest that NO is, or is very closely associated with, the non-adrenergic, non-cholinergic neurotransmitter mediating neurogenic relaxation of the human internal anal sphincter. 相似文献
67.
Anne-Sofie Caroline Jensen Christoffer Polcwiartek Peter Søgaard Rikke Nørmark Mortensen Line Davidsen Mette Aldahl Matilde Alida Eriksen Kristian Kragholm Christian Torp-Pedersen Steen Møller Hansen 《The American journal of medicine》2019,132(2):200-208.e1
Background
Patients with chronic heart failure have vulnerable myocardial function and are susceptible to electrolyte disturbances. In these patients, diuretic treatment is frequently prescribed, though it is known to cause electrolyte disturbances. Therefore, we investigated the association between altered calcium homeostasis and the risk of all-cause mortality in chronic heart failure patients.Methods
From Danish national registries, we identified patients with chronic heart failure with a serum calcium measurement within a minimum 90 days after initiated treatment with both loop diuretics and angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Patients were divided into 3 groups according to serum calcium levels, and Cox regression was used to assess the mortality risk of <1.18 mmol/L (hypocalcemia) and >1.32 mmol/L (hypercalcemia) compared with 1.18 mmol/L–1.32 mmol/L (normocalcemia) as reference. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated.Results
Of 2729 patients meeting the inclusion criteria, 32.6% had hypocalcemia, 63.1% normocalcemia, and 4.3% hypercalcemia. The highest mortality risk was present in early deaths (≤30 days), with a HR of 2.22 (95% CI; 1.74-2.82) in hypocalcemic patients and 1.67 (95% CI; 0.96-2.90) in hypercalcemic patients compared with normocalcemic patients. As for late deaths (>30 days), a HR of 1.52 (95% CI; 1.12-2.05) was found for hypocalcemic patients and a HR of 1.87 (95% CI; 1.03-3.41) for hypercalcemic patients compared with normocalcemic patients. In adjusted analyses, hypocalcemia and hypercalcemia remained associated with an increased mortality risk in both the short term (≤30 days) and longer term (>30 days).Conclusion
Altered calcium homeostasis was associated with an increased short-term mortality risk. Almost one-third of all the heart failure patients suffered from hypocalcemia, having a poor prognosis. 相似文献68.
Caitlin N. Murphy Martin S. Mortensen Karen A. Krogfelt Steven Clegg 《Infection and immunity》2013,81(8):3009-3017
Catheter-associated urinary tract infections are biofilm-mediated infections that cause a significant economic and health burden in nosocomial environments. Using a newly developed murine model of this type of infection, we investigated the role of fimbriae in implant-associated urinary tract infections by the Gram-negative bacterium Klebsiella pneumoniae, which is a proficient biofilm former and a commonly isolated nosocomial pathogen. Studies have shown that type 1 and type 3 fimbriae are involved in attachment and biofilm formation in vitro, and these fimbrial types are suspected to be important virulence factors during infection. To test this hypothesis, the virulence of fimbrial mutants was assessed in independent challenges in which mouse bladders were inoculated with the wild type or a fimbrial mutant and in coinfection studies in which the wild type and fimbrial mutants were inoculated together to assess the results of a direct competition in the urinary tract. Using these experiments, we were able to show that both fimbrial types serve to enhance colonization and persistence. Additionally, a double mutant had an additive colonization defect under some conditions, indicating that both fimbrial types have unique roles in the attachment and persistence in the bladder and on the implant itself. All of these mutants were outcompeted by the wild type in coinfection experiments. Using these methods, we are able to show that type 1 and type 3 fimbriae are important colonization factors in the murine urinary tract when an implanted silicone tube is present. 相似文献
69.